Chubb stock price target raised to $309 by Goldman Sachs on capital deployment

Investing.comMonday, October 27, 2025 at 2:49:54 PM
Chubb stock price target raised to $309 by Goldman Sachs on capital deployment
Goldman Sachs has raised its stock price target for Chubb to $309, highlighting the company's effective capital deployment strategies. This adjustment reflects confidence in Chubb's financial health and growth potential, which is significant for investors looking for stable returns in the insurance sector.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Saudi Power Broker Attias Sees Uplift in FII Dealmaking
PositiveFinancial Markets
The Future Investment Initiative in Riyadh is set to showcase major players in finance, highlighting Saudi Arabia's growing appeal as an investment hub. With leaders from Blackstone and BlackRock looking to invest in the new AI firm Humain, and Goldman Sachs eyeing the private credit market, this event underscores the kingdom's strategic push to attract global capital. Richard Attias, CEO of the FII Institute, emphasizes the importance of these partnerships for economic growth, making this initiative a pivotal moment for Saudi Arabia's financial landscape.
Goldman in talks for $10 billion mandate from Kuwait, Bloomberg News reports
PositiveFinancial Markets
Goldman Sachs is reportedly in discussions to secure a significant $10 billion mandate from Kuwait, according to Bloomberg News. This potential deal highlights the growing interest of major financial institutions in the Middle Eastern markets and could lead to increased investment opportunities in the region. If finalized, this mandate would not only bolster Goldman's portfolio but also strengthen its presence in Kuwait's financial landscape.
Goldman Sachs upgrades Victoria’s Secret stock rating to Neutral from Sell
PositiveFinancial Markets
Goldman Sachs has upgraded Victoria's Secret stock rating from Sell to Neutral, signaling a more optimistic outlook for the company. This change reflects a potential recovery in the brand's performance and could attract investors who were previously hesitant. The upgrade is significant as it may indicate that the company is on a path to improve its market position, which is crucial for its long-term success.
Goldman Sachs reinstates DoorDash stock with Buy rating following Deliveroo deal
PositiveFinancial Markets
Goldman Sachs has reinstated its Buy rating for DoorDash stock, following the company's recent deal with Deliveroo. This move signals confidence in DoorDash's growth potential and market position, especially as it navigates the competitive food delivery landscape. Investors may see this as a positive indicator of DoorDash's future performance, making it an attractive option in the tech and food service sectors.
Goldman Sachs revisits gold price target for 2026
NeutralFinancial Markets
Gold prices have experienced significant fluctuations recently, reaching record highs of nearly $4,400 per ounce before a sharp decline of over 6% on October 21. This volatility has led to discussions among investors and analysts about the future of gold in the market. Goldman Sachs has revisited its price target for 2026, indicating that despite the recent downturn, there may still be potential for growth in the long term. Understanding these trends is crucial for investors looking to navigate the precious metals market.
Goldman Pitches Petco Debt Refinancing as Finances Strengthen
PositiveFinancial Markets
Goldman Sachs is exploring investor interest in refinancing Petco's $1.6 billion term loan, a move that reflects the company's strengthened financial position. This is significant as it indicates confidence in Petco's recovery and growth potential, which could lead to better financial stability and opportunities for the company moving forward.
Latest from Financial Markets
Home Office squandered billions on asylum hotels, MPs say
NegativeFinancial Markets
A recent report by MPs reveals that the Home Office has wasted billions on asylum hotels due to flawed contracts and incompetent delivery. This mismanagement has left the department struggling to meet the growing demand for asylum accommodation, raising concerns about the effectiveness of government spending and the treatment of asylum seekers in the UK.
Argentine bonds and currency surge after victory for Javier Milei’s party
PositiveFinancial Markets
Argentina's financial markets are experiencing a significant boost following the electoral victory of Javier Milei's party. Investors are optimistic that this endorsement will ensure the continuation of the president's market-friendly reforms, which are crucial for the country's economic stability and growth. This surge in bonds and currency reflects a renewed confidence in Argentina's economic direction, making it a pivotal moment for both local and international investors.
Caroline Flack’s Mother Reveals Heartbreaking Regret in Disney+ Documentary
NegativeFinancial Markets
In a poignant new Disney+ documentary, Caroline Flack's mother opens up about her deep regrets following her daughter's tragic death. This heartfelt revelation sheds light on the struggles faced by those dealing with mental health issues and the importance of support systems. It matters because it encourages conversations around mental health and the impact of loss, reminding us to cherish our loved ones and seek help when needed.
Keurig Dr Pepper Soars; Carter's Falls; Avidity Biosciences Rallies
PositiveFinancial Markets
Keurig Dr Pepper's shares have surged ahead of the New York market opening after the company raised its fiscal 2025 sales growth forecast to a high-single-digit range, a significant upgrade from its previous outlook. This positive shift comes alongside a $7 billion financing deal with Apollo and KKR to support its acquisition of JDE Peet’s NV, addressing investor concerns about debt levels. Meanwhile, Carter's shares have declined, and Avidity Biosciences has seen a rally, highlighting the dynamic nature of the stock market.
Shaw Thomas, president and CEO of Retractable, buys $338 in RVP
PositiveFinancial Markets
Shaw Thomas, the president and CEO of Retractable, has made a notable investment by purchasing $338 in RVP. This move highlights his confidence in the company's future and could signal positive growth ahead. Such investments from leadership often inspire trust among stakeholders and can lead to increased interest in the company's performance.
Revolution Medicines stock rises after FDA grants Orphan Drug Designation
PositiveFinancial Markets
Revolution Medicines saw a significant boost in its stock price following the FDA's decision to grant Orphan Drug Designation for its promising treatment. This designation is crucial as it provides incentives for the development of drugs aimed at rare diseases, potentially leading to faster market access and increased funding opportunities. Investors are optimistic about the company's future prospects, as this recognition could pave the way for successful clinical trials and ultimately benefit patients in need.